A
Agilent Technologies Inc (A) Sec Form 8K
Agilent Technologies Inc (NYSE: A) Sec Form 8K
Agilent Technologies Inc (A) Q1 2026 Earnings Results
Agilent Technologies Inc (NYSE: A) Q1 2026 Earnings Release
Agilent Technologies Inc (A) Q1 2026 Earnings Call
Agilent Technologies Inc (NYSE: A) Q1 2026 Earnings Conference
Agilent Technologies Inc (A) TD Cowen’s 46th Annual Health Care Conference
Agilent Technologies Inc (NYSE: A) FY 2026 Corporate Conference
Agilent Technologies Inc (A) Dividend Update
Agilent Technologies Inc (NYSE: A) Q1 2026 Dividend Update
Agilent Technologies Inc (A) Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award
Agilent Technologies Inc (NYSE: A) FY 2026 Other Release
Agilent Technologies Inc (A) Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)
Agilent Technologies Inc (NYSE: A) FY 2026 Other Release